69050006: Physostigmine salicylate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Acetylcholinesterase inhibitor\Reversible anticholinesterase\Physostigmine salicylate

\Drug or medicament (substance)\Autonomic agent (substance)\Parasympathomimetic agent (substance)\...

\Acetylcholinesterase inhibitor\Reversible anticholinesterase\Physostigmine salicylate

\Miotic (substance)\Physostigmine salicylate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Carbamate (substance)\Carbamate ester (substance)\Phenylcarbamate (substance)\Physostigmine salicylate

\Ester\Carbamate ester (substance)\Phenylcarbamate (substance)\Physostigmine salicylate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

114694015 Physostigmine salicylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

114695019 Eserine salicylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

808952011 Physostigmine salicylate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

833451000172119 salicylate de physostigmine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

833461000172117 fysostigminesalicylaat nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Physostigmine salicylate	Is a	Product containing physostigmine (medicinal product)	false	Inferred relationship	Some
Physostigmine salicylate	Is a	Physostigmine (substance)	false	Inferred relationship	Some
Physostigmine salicylate	Has disposition (attribute)	Acetylcholine receptor agonist (disposition)	false	Inferred relationship	Some
Physostigmine salicylate	Has disposition (attribute)	Cholinesterase inhibitor	false	Inferred relationship	Some
Physostigmine salicylate	Is a	Miotic (substance)	true	Inferred relationship	Some
Physostigmine salicylate	Is a	Phenylcarbamate (substance)	true	Inferred relationship	Some
Physostigmine salicylate	Is a	Reversible anticholinesterase	true	Inferred relationship	Some
Physostigmine salicylate	Is modification of (attribute)	Physostigmine (substance)	true	Inferred relationship	Some
Physostigmine salicylate	Has disposition (attribute)	Reversible anticholinesterase	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Physostigmine salicylate 1mg/mL injection solution ampule	Has active ingredient	False	Physostigmine salicylate	Inferred relationship	Some
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Has basis of strength substance (attribute)	True	Physostigmine salicylate	Inferred relationship	Some	2
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution	Has precise active ingredient	True	Physostigmine salicylate	Inferred relationship	Some	2
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	Has precise active ingredient	True	Physostigmine salicylate	Inferred relationship	Some	1
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	Has basis of strength substance (attribute)	True	Physostigmine salicylate	Inferred relationship	Some	1
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug)	Has precise active ingredient	True	Physostigmine salicylate	Inferred relationship	Some	1
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug)	Has basis of strength substance (attribute)	True	Physostigmine salicylate	Inferred relationship	Some	1
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)	Has basis of strength substance (attribute)	True	Physostigmine salicylate	Inferred relationship	Some	2
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)	Has precise active ingredient	True	Physostigmine salicylate	Inferred relationship	Some	2
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)	Has basis of strength substance (attribute)	True	Physostigmine salicylate	Inferred relationship	Some	2
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)	Has precise active ingredient	True	Physostigmine salicylate	Inferred relationship	Some	2

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug